Table 1

Baseline clinical characteristics

No NRI
N=35 611
NRI
N=1134
NDR
N=225
P value
Age (years)65.3±12.171.2±12.865.0±13.3<0.001
Female sex8381 (23.5)345 (30.4)49 (21.8)<0.001
Length of stay (days)3 (1–4)6 (4–11)10 (4–19)<0.001
BMI (kg/m2)28.8±5.528.2±5.628.9±6.0<0.001
Previous PCI10 447 (29.3)270 (23.8)44 (19.7)<0.001
Previous CABG2406 (6.8)105 (9.3)15 (6.7)0.004
Diabetes mellitus7857 (22.1)431 (38.0)85 (38.1)<0.001
Peripheral vascular disease1222 (3.4)93 (8.2)24 (10.8)<0.001
Cerebrovascular disease1331 (3.7)87 (7.7)18 (8.1)<0.001
Renal function (eGFR; mL/min/1.73 m2)
 Stages I–II (>60)25 944 (72.8)488 (43.0)89 (39.6)<0.001
 Stage IIIa (45–59)3761 (10.6)214 (18.9)40 (17.8)<0.001
 Stage IIIb (30–44)2144 (6.0)193 (17.0)32 (14.2)<0.001
 Stages IV–V (<30)882 (2.4)157 (13.8)50 (22.2)<0.001
 Chronic dialysis437 (1.2)59 (5.21)NA<0.001
LVEF
 Normal (≥50%)19 821 (63.1)358 (34.7)41 (19.9)<0.001
 Mild (45–49%)6399 (20.4)209 (20.3)34 16.5)
 Moderate (35–44%)3604 (11.5)235 (22.8)49 23.8)
 Severe (<35%)1569 (5.0)229 (22.2)82 (39.8)
Clinical presentation
 STEMI9678 (27.2)595 (52.5)134 (59.6)<0.001
 NSTEMI9650 (27.1)283 (25.0)50 22.7)
 UAP2430 (6.8)43 (3.8)3 (1.3)
 Non-ACS13 853 (38.9)213 (18.8)37 (16.4)
Cardiogenic shock781 (2.2)204 (18.0)100 (44.4)<0.001
OHCA922 (2.6)101 (8.9)56 (24.9)<0.001
IHCA560 (1.6)80 (7.1)46 (20.5)<0.001
Urgent PCI21 749 (61.1)944 (83.3)200 (88.9)<0.001
  • Values are expressed as mean±SD or n (%). Length of stay expressed as median days (IQR).

  • ACS, acute coronary syndrome; BMI, body mass index; CABG, coronary artery bypass graft; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; IHCA, In hospital cardiac arrest; LVEF, left ventricular ejection fraction; NDR, new dialysis requirement; NRI, new renal impairment; NSTEMI, non-ST elevation myocardial infarction; OHCA, out-of-hospital cardiac arrest; PCI, percutaneous coronary intervention; STEMI, ST elevation myocardial infarction; UAP, unstable angina pectoris.